As a clinician, Tschp had become incredibly frustrated by the lack of an effective treatment for patients he saw with obesity
The drug, originally developed to help treat diabetes, has proven itself remarkably useful in reducing obesity-related diseases, slowing kidney disease, and may even help with addiction and cognitive decline
When evaluating any program, prioritize those that include live instruction, hands-on clinical components, prescribing protocols you can implement immediately, and ongoing support after completion
[DOI] [PMC free article] [PubMed] [Google Scholar] 274.Bjrnholm, K
Weight Management Medication This entire discussion highlights a critical principle in healthcare, one we're passionate about at TrimrX: using the right tool for the right job
Policy The finding, achieved with weekly injections of the GLP-1 receptor agonist semaglutide (Wegovy, Ozempic) in the multicenter SELECT trial, establishes overweight/obesity as a modifiable risk factor for CVD, according to lead investigator A
